Skin diseases such as atopic dermatitis, psoriasis, and urticarial afflict millions of people worldwide, affecting their physical and emotional well-being.

In recent years, Novartis, a global pharmaceutical company, has been providing care, resources, and support to patients and caregivers.

Atopic Dermatitis

Atopic dermatitis, also known as eczema, is a common skin condition characterized by inflamed, itchy skin. It affects both children and adults, and there is no known cure.

However, Novartis has been working on ways to manage and alleviate the symptoms of atopic dermatitis through research and development of new treatments, such as the biologic drug, dupilumab.

Psoriasis

Psoriasis is an autoimmune disease that causes raised, scaly patches on the skin. It can be painful, itchy, and embarrassing, and affects people of all ages.

Novartis has been at the forefront of psoriasis treatment with its products, such as Cosentyx, which has been shown to improve skin symptoms and joint pain associated with psoriasis.

Urticaria

Urticaria, also known as hives, is a skin condition characterized by raised, itchy welts that can appear anywhere on the body. It can be chronic, lasting for six weeks or more, or acute, lasting for less than six weeks.

Novartis has developed a range of treatments for urticaria, such as Xolair, an injectable medication that helps to block the inflammatory response that causes hives.

Support for Patients and Caregivers

Novartis understands that skin diseases can have a significant impact on patients and their families. That’s why the company offers resources and support to help patients and caregivers better manage their condition.

For instance, Novartis has partnered with the National Eczema Association to create an online community for people with atopic dermatitis. The community provides information, resources, and a platform for patients to connect with each other and share their experiences.

Novartis has also launched a program called the “Skin to Live In” initiative, which aims to raise awareness about the impact of psoriasis on people’s lives.

The initiative features a social media campaign, patient stories, and a website with information and resources for patients and caregivers.

Clinical Trials

Novartis is committed to advancing the field of dermatology by conducting clinical trials for new treatments for skin diseases. Clinical trials are vital to finding new treatments and improving the lives of patients.

Novartis has invested in clinical trials for atopic dermatitis, psoriasis, and urticaria, among other dermatological conditions.

Conclusion

Skin diseases can be challenging to manage, but Novartis is dedicated to providing care, resources, and support to patients and caregivers.

Through research and development of new treatments, advocacy, and education, Novartis is making a difference in the lives of millions of people affected by skin diseases.